Company / Cash & Equivalents
CareDx, Inc. Cash & Equivalents History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash & Equivalents
$65.4M
FY2025
5-year range
$65.4M / $348.5M
FY2021-FY2025
Trend
-43.0%
vs FY2024
Sector context
#128 of 152
Health Care
What the data says
CareDx, Inc.'s cash & equivalents of $65M is lower than 84% of companies in the Health Care sector (FY2025). Cash & Equivalents has fluctuated over the past 10 years, ranging from $17M in FY2017 to $348M in FY2021.
Based on SEC 10-K filings.
$65M in FY2025 with a 5-year CAGR of -13.4%.
Declined from $82M to $65M over the past 2 years.
Health Care sector context is included.
Cash & Equivalents over time
Growth rates
- 3-Year CAGR
- -10.1%
- 5-Year CAGR
- -13.4%
- 10-Year CAGR
- -
Sector benchmark
Bottom 16% in Health CareTop 84% of 152This company $65.4M Sector average $1.2B
▼
-94.4% below sector average
Key checks
Key Insights
- 5-year CAGR of -13.4%, indicating a declining trend.
- In FY2025, cash & equivalents decreased 43.0% year-over-year.
- Ranks #128 out of 152 companies in the Health Care sector.
- Peak cash & equivalents was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score 0.62 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash & EquivalentsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $65.4M | -43.0% |
| FY2024 | $114.7M | +39.5% |
| FY2023 | $82.2M | -8.6% |
| FY2022 | $89.9M | -74.2% |
| FY2021 | $348.5M | +158.8% |
| FY2020 | $134.7M | +252.3% |
| FY2019 | $38.2M | -40.8% |
| FY2018 | $64.6M | +282.5% |
| FY2017 | $16.9M | -2.1% |
| FY2016 | $17.3M | -42.3% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026